Loading…
DIA Europe 2019 has ended
Back To Schedule
Wednesday, February 6 • 15:15 - 16:15
#S0103: The Regulatory Role in EU Public-Private Partnerships (PPPs)

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session

This forum will discuss how regulatory contribution to EU public-private partnerships like the Innovative Medicines Initiative (IMI) was critical for its outcomes and for the advancement of EU regulatory science. Panelists will reflect on past and current achievements, while looking beyond 2019 and towards the new Framework Programme 9 (Horizon Europe), reflecting on possible partnerships that can bring added value to drug development and healthcare in the EU and globally.

Chair

João Duarte, MPharm, MSc

Speaker

Panel Discussion
Magda Chlebus, MA

Panel Discussion
Solange Corriol-Rohou, DrMed, MD, PhD

Panel Discussion
David Haerry



Speakers
avatar for João Duarte

João Duarte

Director, Chief of Staff & Regulatory Science, Alexion Pharmaceuticals, France
João Duarte is currently Chief of Staff and Regulatory Science within the Global Regulatory Affairs team at Alexion Pharmaceuticals. João leads the regulatory intelligence and policy activities globally and supports Senior Management in steering internal activities based on the... Read More →
MC

Magda Chlebus

Executive Director Science Policy & Regulatory Affairs, EFPIA
Magda Chlebus is Executive Director Science Policy & Regulatory Affairs at the European Federation of Pharmaceutical Industries and Associations (EFPIA), representing the R&D-based pharmaceutical industry in Europe.Magda and her team are in charge of following policy and legislative... Read More →
avatar for Solange Corriol-Rohou

Solange Corriol-Rohou

Senior Director, Global Regulatory Affairs & Policy, Europe, Astrazeneca Research & Development, France
Pulmonologist and immuno-allergologist by training, Solange joined AstraZeneca R&D in 2004. Moving from the French Medicines Agency and hospital to Industry, she has gained strategic experience in drug development. As the chair of the EFPIA Clinical Development Expert Group, she has... Read More →
avatar for David Haerry

David Haerry

Member, European AIDS Treatment Group
David has been involved with health care professionals’ education projects since 2007 and, in 2015, became Secretary General for the Swiss Academic Foundation on Education in Infectious Diseases (SAFE-ID). He has been Work-Package Co-leader and a member of the Executive Committee... Read More →


Wednesday February 6, 2019 15:15 - 16:15 CET
E1 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  01 Stakeholders and Regulatory System Optimisation, Session
  • Featured Topics Regulatory Science
  • Tags Session